annb0t
Top 20
MELBOURNE, Australia and INDIANAPOLIS, Ind., March 4, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) invites investors to join a webinar showcasing the Company's late-stage and next-generation radiotherapeutic candidates in urologic oncology.(PRNewsfoto/Telix Pharmaceuticals Limited)
In this education session, Telix and global key opinion leaders will provide an overview on the development of its therapeutic candidates in prostate and kidney cance...
>>> Read more: Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
In this education session, Telix and global key opinion leaders will provide an overview on the development of its therapeutic candidates in prostate and kidney cance...
>>> Read more: Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
